Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-23
2011-08-23
Allen, Marianne P (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S069100, C435S070100, C435S320100, C435S325000, C530S350000, C530S399000, C530S402000, C530S407000
Reexamination Certificate
active
08003607
ABSTRACT:
An HGF precursor protein variant, in which a peptide structure comprises a sequence including a peptide chain X inserted between an α chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the C-terminus of the α chain are deleted, and a β chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the N-terminus of the β chain are deleted; wherein (i) the peptide chain X has an amino-acid sequence of at least two residues, (ii) the peptide chain X can be cleaved by a protease reaction or a chemical reaction, and (iii) a protein obtained by cleaving at least one site of the peptide chain X has HGF action.
REFERENCES:
patent: 5879910 (1999-03-01), Godowski et al.
patent: 7098002 (2006-08-01), Rubinstein et al.
patent: 7220569 (2007-05-01), Himmelspach et al.
patent: 7351540 (2008-04-01), Carr
patent: 2003/0124653 (2003-07-01), Canfield
patent: 2004/0138120 (2004-07-01), Kirchhofer et al.
T. Nakamura, “Kansaibo Zoshoku Inshi (HGF) no Bunshi Cloning”, Experimental Medicine, 1990, vol. 8, No. 3, pp. 250-255 with an English translation thereof.
S. M. Hunt et al.,“Processing of mutated human proinsulin to mature insulin in the non-endocrine cell line, CHO”, Cytotechnology, vol. 21, No. 3, pp. 279-288, 1996.
Peek, Mark et al., “Unusual Proteolytic Activation of Pro-hepatocyte Growth Factor by Plasma Kallikrein and Coagulation Factor Xla,” Journal of Biological Chemistry, vol. 277, No. 49, Dec. 6, 2002, pp. 47804-47809.
Adachi Kiichi
Fukuta Kazuhiro
Hayata Daichika
Matsumoto Kunio
Nakamura Toshikazu
Allen Marianne P
Kringle Pharma Inc.
Osaka University
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
HGF precursor protein variant and active protein thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HGF precursor protein variant and active protein thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HGF precursor protein variant and active protein thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2725798